Aminopyridine derived compounds as LRRK2 inhibitors

The present invention is directed to aminopyridine derived compounds of formula (A) The compounds are considered useful for the treatment of diseases associated with LRRK2 such as a Lewy body dementia, Parkinson's disease or cancer.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: DAVID LAURENT, WILLIAMSON DOUGLAS STEWART, MIKKELSEN GITTE KOBBERØE, WATSON STEPHEN, SMITH GARRICK PAUL, CHEN I-JEN
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator DAVID LAURENT
WILLIAMSON DOUGLAS STEWART
MIKKELSEN GITTE KOBBERØE
WATSON STEPHEN
SMITH GARRICK PAUL
CHEN I-JEN
description The present invention is directed to aminopyridine derived compounds of formula (A) The compounds are considered useful for the treatment of diseases associated with LRRK2 such as a Lewy body dementia, Parkinson's disease or cancer.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US9393248B1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US9393248B1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US9393248B13</originalsourceid><addsrcrecordid>eNrjZDB2zM3Myy-oLMpMycxLVUhJLcosS01RSM7PLcgvzUspVkgsVvAJCvI2UsjMy8hMyizJLyrmYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXxocGWxpbGRiYWTobGRCgBAKoVLCU</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Aminopyridine derived compounds as LRRK2 inhibitors</title><source>esp@cenet</source><creator>DAVID LAURENT ; WILLIAMSON DOUGLAS STEWART ; MIKKELSEN GITTE KOBBERØE ; WATSON STEPHEN ; SMITH GARRICK PAUL ; CHEN I-JEN</creator><creatorcontrib>DAVID LAURENT ; WILLIAMSON DOUGLAS STEWART ; MIKKELSEN GITTE KOBBERØE ; WATSON STEPHEN ; SMITH GARRICK PAUL ; CHEN I-JEN</creatorcontrib><description>The present invention is directed to aminopyridine derived compounds of formula (A) The compounds are considered useful for the treatment of diseases associated with LRRK2 such as a Lewy body dementia, Parkinson's disease or cancer.</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2016</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20160719&amp;DB=EPODOC&amp;CC=US&amp;NR=9393248B1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76516</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20160719&amp;DB=EPODOC&amp;CC=US&amp;NR=9393248B1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>DAVID LAURENT</creatorcontrib><creatorcontrib>WILLIAMSON DOUGLAS STEWART</creatorcontrib><creatorcontrib>MIKKELSEN GITTE KOBBERØE</creatorcontrib><creatorcontrib>WATSON STEPHEN</creatorcontrib><creatorcontrib>SMITH GARRICK PAUL</creatorcontrib><creatorcontrib>CHEN I-JEN</creatorcontrib><title>Aminopyridine derived compounds as LRRK2 inhibitors</title><description>The present invention is directed to aminopyridine derived compounds of formula (A) The compounds are considered useful for the treatment of diseases associated with LRRK2 such as a Lewy body dementia, Parkinson's disease or cancer.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2016</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDB2zM3Myy-oLMpMycxLVUhJLcosS01RSM7PLcgvzUspVkgsVvAJCvI2UsjMy8hMyizJLyrmYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXxocGWxpbGRiYWTobGRCgBAKoVLCU</recordid><startdate>20160719</startdate><enddate>20160719</enddate><creator>DAVID LAURENT</creator><creator>WILLIAMSON DOUGLAS STEWART</creator><creator>MIKKELSEN GITTE KOBBERØE</creator><creator>WATSON STEPHEN</creator><creator>SMITH GARRICK PAUL</creator><creator>CHEN I-JEN</creator><scope>EVB</scope></search><sort><creationdate>20160719</creationdate><title>Aminopyridine derived compounds as LRRK2 inhibitors</title><author>DAVID LAURENT ; WILLIAMSON DOUGLAS STEWART ; MIKKELSEN GITTE KOBBERØE ; WATSON STEPHEN ; SMITH GARRICK PAUL ; CHEN I-JEN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US9393248B13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2016</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>DAVID LAURENT</creatorcontrib><creatorcontrib>WILLIAMSON DOUGLAS STEWART</creatorcontrib><creatorcontrib>MIKKELSEN GITTE KOBBERØE</creatorcontrib><creatorcontrib>WATSON STEPHEN</creatorcontrib><creatorcontrib>SMITH GARRICK PAUL</creatorcontrib><creatorcontrib>CHEN I-JEN</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>DAVID LAURENT</au><au>WILLIAMSON DOUGLAS STEWART</au><au>MIKKELSEN GITTE KOBBERØE</au><au>WATSON STEPHEN</au><au>SMITH GARRICK PAUL</au><au>CHEN I-JEN</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Aminopyridine derived compounds as LRRK2 inhibitors</title><date>2016-07-19</date><risdate>2016</risdate><abstract>The present invention is directed to aminopyridine derived compounds of formula (A) The compounds are considered useful for the treatment of diseases associated with LRRK2 such as a Lewy body dementia, Parkinson's disease or cancer.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US9393248B1
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title Aminopyridine derived compounds as LRRK2 inhibitors
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-20T20%3A08%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=DAVID%20LAURENT&rft.date=2016-07-19&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS9393248B1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true